Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective

Biological Psychiatry

Volumn 46, Issue 6, 1999, Pages 729-739

  Lieberman, Jeffrey A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Kraepelin; Neurobiology; Neurodegeneration; Neurodevelopment; Pathophysiology; Schizophrenia

Indexed keywords

COGNITION; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE PREDISPOSITION; HUMAN; NEUROBIOLOGY; NEUROPSYCHIATRY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

BRAIN DISEASES; CHRONIC DISEASE; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; NERVE DEGENERATION; PSYCHOLOGICAL THEORY; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032821589     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00147-X     Document Type: Review

References (91)

1. Arnold S.E., Trojanowski J.Q., Gur R.E., Blackwell P., Han L., Choi C. Absence of neurodegeneration and neural injury in the cerebral cortex in a sam ple of elderly patients with schizophrenia. Arch Gen Psychiatry. 55:1998;225-232.
2. Baum K.M., Walker E.F. Childhood behavioural precursors of adult symptom dimensions in schizophrenia. Schizophr Res. 16:1995;111-120.
3. Benes F.M. Is there a neuroanatomic basis for schizophrenia? An old question revisited. The Neurosci. 1:1995;104-115.
4. Bilder R.M., Lipschutz-Broch, Reiter G., Geisler S.H., Mayerhoff D.I., Lieberman J.A. Intellectual deficits in first-episode schizophrenia Evidence for progressive deterioration . Schizophr Bull. 18:1992;437-488.
5. Bloom F.E. Advancing a neurodevelopmental origin for schizophrenia. Arch Gen Psychiatry. 50:1993;224-227.
6. Bogerts B. Recent advances in the neuropathology of schizophrenia. Schizophr Bull. 19:1993;431-445.
7. Bredesen D.E. Neural apoptosis. Ann Neurol. 38:1995;839-851.
8. Buchsbaum M.S., Haier R.J., Potkin S.G., Neuchterlein K., Bracha H.S., Katz M., et al. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Arch Gen Psychiatry. 49:1992;935-942.
9. Buchsbaum M.S., Potkin S.G., Siegel B.V. Jr, Lohr J., Katz M., Gottschalk L.A., et al. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Arch Gen Psychiatry. 49:1992;966-974.
10. Chatterjee and Lieberman (in press): Studies of first episode schizophrenia: A comprehensive review. In: McGorry P, Jackson H, editors: The Recognition and Management of Early Psychosis. Cambridge (UK): Cambridge University Press.
11. Cleghorn J.M., Garnett E.S., Nahmias C., Firnau G., Brown G.M., Kaplan R., et al. Increased frontal and reduced parietal glucose metabolism in acute untreated schizophrenia. Psych Res. 28:1989;119-133.
12. Coyle J.T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
13. Davidson M., Harvey P.D., Powchik P., Parella M., White L., Knobler H.Y., et al. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry. 152:1995;197-207.
14. Davis K.L., Buchsbaum M.S., Shihabuddin L., Spiegel-Cohen J., Metzger M., Frecska E., et al. Ventricular enlargement in poor-outcome schizophrenia. Biol Psychiatry. 43:1998;783-793.
15. Davis J.M., Andriukaitis S. The natural course of schizophrenia and effective maintenance drug treatment. J Clin Psychopharmacol. 6:1986;2S-10S.
16. DeLisi L.E., Twe W., Xie S.-H., Hoff A.L., Sakuma M., Kushner M., et al. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients Preliminary findings . Biol Psychiatry. 38:1995;349-360.
17. Done D.J., Crow T.J., Johnstone E.C., Sacker A. Childhood antecedents of schizophrenia and affective illness Social adjustment at ages 7 and 11 . BMJ. 309:1994;699-703.
18. Fenton W.S., McGlashan T.H. Antecedents, symptom progression, and long-term outcome of the deficit syndrome in schizophrenia. Am J Psychiatry. 151:1994;351-356.
19. Franzen G, Ingvar DH (1975): Absence of activation in frontal structures during psychological testing of chronic schziophrenics. J of Neurol, Neurosurg and Psych 1027-1032.
20. Frazier J.A., Giedd J.N., Hamburger S.D., Albus K.E., Kaysen D., Vaituzis A.C., et al. Brain anatomic magnetic resonance imaging in childhood-onset schizophrenia. Arch Gen Psychiatry. 53:1996;617-624.
21. Goldberg T.E., Gold J.M. Neurocognitive deficits in schizophrenia. Hirsch S.R., Weinberger D.R. Schizophrenia. 1995;146-162 Blackwell, Oxford.
22. Goldman-Rakic P.S., Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schiz Bull. 23:1997;437-458.
23. Green M., Satz P., Christenson C. Minor physical abnormalities in schizophrenic patients, bipolar patients and their siblings. Schizophrenia Bull. 20:1994;433-449.
24. Gur R.E., Cowell P., Turetsky B.I., Gallacher N., Cannon T., Bilker W., et al. A follow-up magnetic resonance imaging study of schizophrenia Relationship of neuroanatomical changes to clinical and neurobehavioral measures . Arch Gen Psychiatry. 55:1998;145-152.
25. Hardy J., Gwinn-Hardy K. Genetic classification of primary neurodegenerative disease. Science. 282:1998;1075-1079.
26. Hare E.H. The changing content of psychiatric illness. J Psychosom Res. 18:1974;283-289.
27. Haug O.J. Pneumoencephalographic studies in mental health. Acta Psychiatry Scand Suppl. 165:1962;1-114.
28. Heaton R., Paulsen J.S., McAdams L.A., Kuck J., Zisook S., Braff D., et al. Neuropsychological deficits in schizophrenia. Arch Gen Psych. 51:1994;469-476.
29. Hegarty J.D., Baldessarini R.J., Tohen M., Waternaux C., Oepen G. One hundred years of schizophrenia a meta-analysis of the outcome literature . Am J Psychiatry. 151:1994;1409-1416.
30. Hoff A.L., Riordan H., O'Donnel D.W., Morris L., Delisi L.E. Neuropsychological functioning in first-episode schizophreniform patients. Am J Psychiatry. 149:1992;898-903.
31. Horrobin D.F., Geln A.I.M., Vaddadi K. The membrane hypothesis of schizophrenia. Schizophr Res. 13:1994;195-207.
32. Huber G., Gross G., Shuttler R., Linz M. Longitudinal studies of schizophrenic patients. Schizophr Bull. 6:1980;592-605.
33. Huber G. Pneumoencephalographische und psychopathologische Bilder beiendogen Psychosen. 1954;Springer International, Berlin.
34. Illowsky B.P., Juliano D.M., Migelow L.B., Weinberger D.R. Stability of CT scan findings in schizophrenia Results of an 8-year follow-up study . J Neurol Neurosurg Psychiatry. 51:1988;209-213.
35. Jacobi W., Winkler H. Zur Frage der Spratschadigungen nach Encephalographie. Deutsche Ztschr. f. Nervenh. 112:1930;266-280.
36. Jaskiw G.E., Juliano D.M., Goldberg T.E., Hertzman M., Urow-Harnell E., Weinberger D.R. Cerebral ventricular enlargement in schizophreniform disorder does not progress. A seven year follow-up study. Schizopr Res. 14:1994;23-28.
37. Johnstone E.C. Disabilities and circumstances of schizophrenic patients A follow-up study . Br J Psychiatry. 159:1991;5-46.
38. Jones P., Rodgers B., Murray R., Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 344:1994;1398-1402.
39. Kemali D., Maj M., Galderisi S., Milici N., Salvati A. Ventricle-to-brain ratio in schizophrenia a controlled follow-up study . Biol Psychiatry. 26:1989;756-759.
40. Kendler K.S., Diehl S.R. The genetics of schizophrenia a current, genetic-epidemiologic perspective . Schizophr Bull. 19:1993;261-285.
41. Keshavan M.S., Bagwell W.W., Haas G.L., Sweeney J.A., Schooler N., Pettegrew J.W. Changes in caudate volume with neuroleptic treatment. Lancet. 344:1994;1434. [letter].
42. Kikinis R., Shenton M.E., Gerig G., et al. Temporal lobe sulco-gyral pattern anomalies in schizophrenia An in vivo MR three-dimensional surface rendering study . Neurosci Lett. 182:1994;7-12.
43. Knoll J.L. 4th, Garver D.L., Ramberg J.E., Kingsbury S.J., Croissant D., McDermott B. Heterogeneity of the psychoses Is there a neurodegenerative psychosis? Schizophr Bull. 24:1998;365-379.
44. Kraeplin E. Dementia Praecox and Paraphrenia. 1919;E&S Livingstone, Edinburgh, Scotland.
45. Lewis D.A. Development of the prefrontal cortex during adolescence Insights into vulnerable neural circuits in schizophrenia . Neuropsychopharmacology. 16:1997;358-398.
46. Lieberman J., Kane J., Woerner M., Alvir J., Borenstein M., Novacenko H. Prediction of relapse in schizophrenia. Clin Neuropharmacol. 13:1990;434-435.
47. Lieberman J.A., Bogerts B., Degreef G., Ashtari M., Alvir J. Qualitative assessment of brain morphology in acute and chronic schizophrenia. Am J Psychiatry. 149:1992;784-794.
48. Lieberman J.A., Alvir J.M., Koreen A., Geisler S., Chakos M., Sheitman B., Woerner M. Psychobiologic correlates of treatment response in schizophrenia. Neuropsychopharmacology. 14:1996;13S-21S.
49. Lieberman J.A., Sheitman B.B., Kinon B.J. Neurochemical sensitization in the pathophysiology of schizophrenia Deficits and dysfunction in neuronal regulation and plasticity . Neuropsychopharmacology. 17:1997;205-229.
50. Lieberman J.A., Sheitman B., Chakos M., Robinson D., Schooler N., Keith S. The development of treatment resistance in patients with schizophrenia A clinical and pathophysiological perspective . J Clin Psychopharmacol. 18:1998;20S-24S.
51. Lim K.O., Adalsteinsson E., Spielman D., et al. Proton MRS imaging of cortex in schizophrenia. Arch Gen Psychiatry. 55:1998;346-352.
52. Loebel A.D., Lieberman J.A., Alvir J.M.J., Mayerhoff D.I., Geisler S.H., Szymanski S.R. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry. 149:1992;1183-1188.
53. Lohr J.B. Oxygen radicals and neuropsychiatric illness Some speculations . Arch Gen Psych. 48:1991;1097-1106.
54. Margolis R.L., Chuang D.M., Post R.M. Programmed cell death Implications for neuropsychiatric disorders . Biol Psychiatry. 35:1994;946-956.
55. Mattson M.P., Keller J.N., Begley J.G. Evidence for synaptic apoptosis. Exper Neurology. 153:1998;34-48.
56. McCreadie R.G., Thara R., Kamath S., Padmavathy R., Latha S., Mathrubootham N., et al. Abnormal movements in never-medicated Indian patients with schizophrenia. Br J Psychiatry. 168:1996;221-226.
57. McGlashan T.H. A selective review of recent North American long-term follow-up studies of schizophrenia. Schiz Bull. 14:1988;515-542.
58. McGlashan T.H., Fenton W.S. Subtype progression and pathophysiologic deterioration in early schizophrenia. Schizophr Bull. 19:1993;71-84.
59. Morrison J.R. Changes in subtype diagnosis of schizophrenia 1920-1966 . Am J Psychiatry. 131:1974;674-677.
60. Murray R.M., Lewis S.W. Is schizophrenia a neurodevelopmental disorder? BMJ. 296:1987;681-682.
61. Nasrallah H.A., Olson S.C., McCalley-Whitters M., Chapman S., Jacoby C.G. Cerebral ventricular enlargement in schizophrenia. Arch Gen Psychiatry. 43:1986;157-159.
62. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 52:1995;998-1007.
63. Owens D.G., Johnstone E.C., Frith C.D. Spontaneous involuntary disorders of movement Their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics . Arch Gen Psychiatry. 39:1982;452-461.
64. Pettegrew J.A., Keshavan J.S., Panchalingam K., Strychor S., Kaplan D.B., Tretta M.G., et al. Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naïve schizophrenics. Arch Gen Psychiatry. 48:1991;563-568.
65. Pfohl B., Winokur G. The evolution of symptoms in institutionialized hebephrenic/catatonic schizophrenics. Br J Psychiatry. 141:1982;567-572.
66. Purohit D.P., Perl D.P., Haroutunian V., Powchik P., Davidson M., Davis K.L. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia A postmortem neuropathologic study of 100 cases . Arch Gen Psychiatry. 55:1998;205-211.
67. Rajkowska G., Selemon L.D., Goldman-Rakic P.S. Neuronal and glial somal size in the prefrontal cortex. Arch Gen Psychiatry. 55:1998;215-224.
68. Rapoport J.L., Giedd J., Kumra S., Jacobsen L., Smith A., Lee P., et al. Childhood-onset schizophrenia Progressive ventricular change during adolescence . Arch Gen Psych. 54:1997;897-903.
69. Rapoport JL, Giedd JN, Blumental J, Hamburger S, Jeffries N, Fernandez T, et al (1999): Progressive cortical change during adolescence in childhood onset schizophrenia: A longitudinal MRI study. Arch Gen Psychiatry, in press.
70. Reddy R., Yao J.K. Free radical pathology in schizophrenia a review . Prostaglandins Leukot Essent Fatty Acids. 55:1996;33-43.
71. Roberts G.W., Colter N., Lofthouse R., Johnstone E.C., Crow T.J. Is there gliosis in schizophrenia? Investigation of the temporal lobe. Biol Psychiatry. 22:1987;1459-1468.
72. Robinson D., Woerner M., Alvir J., Bilder R., Goldman R., Geisler S., et al. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry. 156:1999;544-549.
73. Saykin A.J., Shtase D.L., Gur R.E., Kester D.B., Mozley L.H., Stafiniak P., et al. Neuropsychological deficits in neuroleptic-naïve patients with first-episode schizophrenia. Arch Gen Psychiatry. 51:1994;124-131.
74. Shenton ME, Wible CG, McCarley RW. MRI studies in schizophrenia. In: Krishnan KRR, Doraiswamy PM, editors: Brain Imaging in Clinical Psychiatry. New York: Marcel Dekker, pp 297-380.
75. Szymanski S.R., Cannon T.D., Gallacher F., Erwin R.J., Gur R.E. Course of treatment response in first-episode and chronic schizophrenia. Am J Psychiatry. 153:1996;519-525.
76. Southard E.E. On the topographical distribution of cortex lesions and anomalies in dementia praecox, with some account of their functional significance. Am J Insanity. 71:1915;603-671.
77. Stanley J.A., Williamson P.C., Drost D.J., Carr T.J., Rylett R.J., Malla A., et al. An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy. Arch Gen Psychiatry. 52:1995;399-406.
78. Stanley J.A., Williamson P.C., Drost D.J., Rylett R.J., Carr T.J., Malla A., et al. An in vivo proton magnetic resonance spectroscopy study of schizophrenia patients. Schiz Bull. 22:1996;597-609.
79. Szechtman H., Nahmias C., Garnett E.S., Firnauy G., Brown G.M. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Arch Gen Psych. 45:1988;523-532.
80. Vita A., Sacchetti E., Valvassori G., Cazzullo C.L. Brain morphology in schizophrenia A 2-to-5-year CT scan follow-up study . Acta Psychiatr Scan. 78:1988;618-621.
81. Vita A., Dieci M., Giobbio G.M., Azzone P., Garbarini M., Sacchetti E., et al. CT scan abnormalities and outcome of chronic schizophrenia. Am J Psychiatry. 148:1991;1577-1579.
82. Waddington J.L., Buckley P.F. The Neurodevelopmental Basis of Schizophrenia. 1996;Landes, Austin (TX).
83. Waddington J.L., Scully P.J., Youssef H.A. Developmental trajectory and disease progression in schizophrenia The conundrum, and insights from a 12-year prospective study in the Monaghan 101 . Schiz Res. 23:1997;107-118.
84. Waddington J.L., Yuossef H.A., Kinsella A. Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychol Med. 25:1995;849-857.
85. Walker E., Savoie T., Davis D. Neuromotor precursors of schizophrenia. Schizophr Bull. 20:1994;441-451.
86. Weinberger D.R. From neuropathology to neurodevelopment. Lancet. 346:1995;552-557.
87. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 44:1987;660-669.
88. Woods B.T. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary Pathogenetic mechanism. Am J Psychiatry. 155:1998;1661-1670.
89. Woods B.T., Yurgelun-Todd D., Benes F.M., Frankenburg F.R., Pope H.G. Jr, McSparren J. Progressive ventricular enlargement in schizophrenia Comparison to bipolar affective disorder and correlation with clinical course . Biol Psychiatry. 27:1990;341-352.
90. Wyatt R.J. Neuroleptics and the natural course of schizophrenia. Schizophr Bull. 17:1991;325-351.
91. Wyatt R.J. Early intervention for schizophrenia can the course of the illness be altered? Biol Psychiatry. 38:1995;1-3.